| CAS: | 115550-35-1 |
| MF: | C17H19FN4O4 |
| MW: | 362.36 |
| EINECS: | 640-416-5 |
| Product Categories: | API;Active Pharmaceutical Ingredients;Aromatics Compounds;Aromatics;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals;115550-35-1 |
| Mol File: | 115550-35-1.mol |
 |
|
| Marbofloxacin Chemical Properties |
| Melting point | 268-269°C (dec.) |
| Boiling point | 571℃ |
| density | 1.55±0.1 g/cm3(Predicted) |
| Fp | >110°(230°F) |
| storage temp. | Inert atmosphere,2-8°C |
| solubility | Chloroform (Slightly, Heated) |
| pka | 6.02±0.20(Predicted) |
| form | neat |
| color | Light Yellow |
| Water Solubility | Soluble in DMSO at 2mg/ml. Soluble in water or ethanol at <1mg/ml |
| Merck | 14,5750 |
| InChI | InChI=1S/C17H19FN4O4/c1-19-3-5-21(6-4-19)14-12(18)7-10-13-16(14)26-9-20(2)22(13)8-11(15(10)23)17(24)25/h7-8H,3-6,9H2,1-2H3,(H,24,25) |
| InChIKey | BPFYOAJNDMUVBL-UHFFFAOYSA-N |
| SMILES | N12C=C(C(O)=O)C(=O)C3=C1C(=C(N1CCN(C)CC1)C(F)=C3)OCN2C |
| CAS DataBase Reference | 115550-35-1(CAS DataBase Reference) |
| Marbofloxacin Usage And Synthesis |
| Brand Name(s) in US | Zeniquin, Marbocyl |
| Description | Marbofloxacin is a fluoroquinolone antibiotic that is active against P. multocida in vitro (MIC = 0.016 μg/ml). It exhibits broad-spectrum antibacterial activity mediated by the inhibition of DNA gyrase, with MIC values ranging from 0.016 to 0.4 and 0.19 to 1.7 μg/ml against various Gram-negative and Gram-positive bacterial isolates, respectively. In vivo, the administration of marbofloxacin (2 mg/kg, i.m.) after infection prevents the formation of pulmonary lesions in a bovine calf model of M. haemolytica A1 pneumonia. Oral marbofloxacin (2 mg/kg per day) also exhibits antileishmanial activity in a canine model of leishmaniasis, decreasing parasitic load by 72%. Formulations containing marbofloxacin have been used in the veterinary treatment of bacterial infections. |
| Chemical Properties | Crystalline Solid |
| Uses | Fluorinated quinolone antibacterial |
| Uses | A broad spectrum antibiotic commonly used to target Pseudomonas and Staphylococci species |
| Definition | ChEBI: A fluoroquinolone antibiotic that is 7-oxo-2,3-dihydro-7H-[1,3,4]oxadiazino[6,5,4-ij]quinoline substituted at positions 6, 9 and 10 by carboxy, fluoro and 4-methylpiperazin-1-yl groups, respectively. A synthetic, broad spect um bactericidal agent, it is used in veterinary medicine, although its mechanism of action is not thoroughly understood. |
| Veterinary Drugs and Treatments | Marbofloxacin is labeled for the treatment of susceptible bacterial infections in dogs and cats. |
Packing &shipping&Payment
Packing:25kg/drum
Shipping:by sea or by air
Payment:T/T,western union,moneygram
Packaging Details drum
Port:Tianjin
Lead Time :
| Quantity(Kilograms) | 1 - 10000 | >10000 |
| Est. Time(days) | 5 | To be negotiated |
Company information
Hebei Mojin Biotechnology Co., Ltd, Our company is a professional in 4'-Methylacetophenone,Levamisole hydrochloride ,N-Methylformamide and other chemical reagents research and development production enterprises. Our business covers more than 30 countries, most of the big customers come from Europe, America and other countries in the world, we can guarantee the quality and price. In recent decades, with the efforts of all employees, we have established many cooperative companies in shandong, henan, guangdong and other places. Our corporate purpose is based on the market, enhance the strength, take the road of scientific and environmental sustainable development, relying on the country. Technology r & d center, increase the investment in r & d, based on the domestic market, expand the international market, manufacturing quality products, sincere service to the society, into a modern, ecological, scientific and technological enterprise world.
Advantage
In stock
Japan
